We are live on ! Find out more
DAWN

Day One Biopharmaceuticals
DAWN

Delisted

DAWN was delisted on the 22nd of April, 2026.

Back to rankings

58 hedge funds and large institutions have $698M invested in Day One Biopharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 5

260% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 5

54% more capital invested

Capital invested by funds: $453M → $698M (+$245M)

36.14% more ownership

Funds ownership: 30.83% → 66.97% (+36%)

29% more funds holding

Funds holding: 45 → 58 (+13)

Holders
58
Holders Change
+13
Holders Change %
+28.89%
% of All Funds
0.89%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.06%
New
18
Increased
25
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$45.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$13.7M
3
DM
Deerfield Management
New York
+$10.1M
4
Franklin Resources
Franklin Resources
California
+$7.62M
5
PCM
Pathway Capital Management
California
+$4.98M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$4.22M
2
Viking Global Investors
Viking Global Investors
Connecticut
-$1.11M
3
DCM
Driehaus Capital Management
Illinois
-$416K
4
LGM
Logos Global Management
California
-$308K
5
MIM
MetLife Investment Management
New Jersey
-$114K
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$875K +$981K +47,737 +1,130%
URS
27
Utah Retirement Systems
Utah
$684K +$833K +40,552 New
TD Asset Management
28
TD Asset Management
Ontario, Canada
$631K +$423K +20,593 +122%
LGM
29
Logos Global Management
California
$624K -$308K -15,000 -29%
SRA
30
Summit Rock Advisors
New York
$558K +$681K +33,125 New
Bank of New York Mellon
31
Bank of New York Mellon
New York
$543K +$112K +5,445 +20%
State of Tennessee, Department of Treasury
32
State of Tennessee, Department of Treasury
Tennessee
$429K +$523K +25,460 New
Goldman Sachs
33
Goldman Sachs
New York
$414K +$504K +24,546 New
N
34
Nuveen
North Carolina
$260K – – –
Morgan Stanley
35
Morgan Stanley
New York
$236K +$226K +10,997 +371%
Prudential Financial
36
Prudential Financial
New Jersey
$235K +$286K +13,935 New
HP
37
Harbourvest Partners
Massachusetts
$226K +$275K +13,388 New
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$226K +$275K +13,404 New
NFGH
39
Nan Fung Group Holdings
Hong Kong
$193K +$235K +11,445 New
ProShare Advisors
40
ProShare Advisors
Maryland
$188K +$229K +11,127 New
Wells Fargo
41
Wells Fargo
California
$180K +$12.3K +599 +6%
VEA
42
Virtus ETF Advisers
New York
$159K +$193K +9,413 New
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$137K +$167K +8,102 New
Deutsche Bank
44
Deutsche Bank
Germany
$113K +$7.46K +363 +6%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$103K +$3.06K +149 +3%
UBS Group
46
UBS Group
Switzerland
$103K +$124K +6,044 +10,244%
AIG
47
American International Group
New York
$99K -$3.6K -175 -3%
Bank of America
48
Bank of America
North Carolina
$96K +$107K +5,201 +1,075%
Citigroup
49
Citigroup
New York
$79K +$69.9K +3,403 +266%
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$55K +$39.6K +1,929 +140%
1
2
3

DAWN Hedge Fund Activity: Q4 2021 in Review

58 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Day One Biopharmaceuticals (DAWN) for Q4 2021, worth a combined $698M — up 54% from $453M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new DAWN positions and 5 closed out — a net gain of 13 holders — while 25 added to existing stakes and 5 trimmed.

The largest buyer was Vanguard Group, adding an estimated $45.5M. The largest seller was Millennium Management, exiting entirely with an estimated $4.22M sold.

  • 58 institutional investors held Day One Biopharmaceuticals (DAWN) as of Q4 2021, up from 45 in Q3 2021.
  • Funds reported $698M of Day One Biopharmaceuticals stock for Q4 2021, up 54% quarter-over-quarter.
  • 18 funds opened new Day One Biopharmaceuticals positions in Q4 2021 and 5 closed out, a net change of +13 holders.
  • The largest Day One Biopharmaceuticals buyer in Q4 2021 was Vanguard Group, an estimated $45.5M added.
  • The largest Day One Biopharmaceuticals seller in Q4 2021 was Millennium Management, an estimated $4.22M sold.

Based on aggregated 13F filings for Q4 2021.